Memo: Corporate Responsibility in the field of Pharmaceuticals

The process on corporate responsibility in the field of pharmaceuticals will be set up to initiate a momentum among the Member States, industry and other relevant stakeholders by considering in a balanced approach societal and industrial challenges. Given the experiences of the G10 process and of the High Level Pharmaceutical Forum, the Process on corporate responsibility in the field of pharmaceuticals should facilitate discussions on ethics and transparency of the sector but also on non-regulatory conditions for better access to medicines after their marketing authorisation.

• Primary Source